At a contentious hearing of the House Energy and Commerce Health Subcommittee on September 9, 2014, lawmakers and the Food and Drug Administration (FDA) clashed over proposed guidance from the FDA regarding the regulation of laboratory developed tests (LDTs). Under the Food and Drug Administration Safety and Innovation Act of 2012, the FDA is required … Continue Reading